H-1B sponsorship profile: Telix Pharmaceuticals US, Inc. Across U.S. Department of Labor LCA disclosures, Telix Pharmaceuticals US, Inc filed 3 Labor Condition Applications covering 3 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 100% (3 certified of 3 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Telix Pharmaceuticals US, Inc’s H-1B petitions range from $152,613 at the low end to $295,000 at the high end, with a petition-weighted average of $200,075. That range reflects the mix of occupations the company sponsors, led by GLOBAL DIRECTOR OF QUALITY (2 petitions at $152,613 avg), followed by Vice President, Clinical Strategic Partnership Alliances. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Telix Pharmaceuticals US, Inc is headquartered in Fishers, IN under NAICS code 3254, and places H-1B workers across 1 state, most heavily in IN. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Telix Pharmaceuticals US, Inc ranks. By H-1B petition volume, Telix Pharmaceuticals US, Inc is #37,433 of 119,880 employers nationally and #333 of 1,210 employers headquartered in IN. Both ranks are computed live from the same underlying petition counts, not a separate estimate.